Trial Profile
Changes in sputum procalcitonin with Bactek -Osublingual vaccine treatment in adult patients with non-cystic fibrosis bronchiectasis: A pilot study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2021
Price :
$35
*
At a glance
- Drugs MV 130 (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
- 23 Sep 2021 Status changed from recruiting to completed.
- 18 Jul 2019 Status changed from not yet recruiting to recruiting.
- 20 Jul 2018 New trial record